U.S. STEM CELL, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-03-09: Form 8-K/A; Period of report 2022-03-04; Description 8.01 Other Events; Details 8.01.
- 2022-03-09: Form 8-K; Period of report 2022-03-04; Description 8.01 Other Events; Details 8.01.
- 2020-05-15: Form 8-K; Period of report 2020-05-15; Description 8.01 Other Events; Details 8.01.
- 2020-03-31: Form 8-K; Period of report 2020-03-31; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-03-09 | 8-K/A | 2022-03-04 | 8.01 Other Events | 8.01 U.S. Stem Cell, Inc. (the “Company”) is pleased to announce that Mark Borman has been appointed as Chairman of the Board of Directors and William P. Murphy, Jr., M.D. has been bestowed with the title of Chairman Emeritus, effective March 4, 2022. | usstem20220309_8ka.htm |
| 2022-03-09 | 8-K | 2022-03-04 | 8.01 Other Events | 8.01 U.S. Stem Cell, Inc. (the “Company”) is pleased to announce that Mark Borman has been appointed as Chairman of the Board of Directors and William P. Murphy, Jr., M.D. has been bestowed with the title of Chairman Emeritus, effective March 4, 2022. | usstem20220304_8k.htm |